Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes: The OASIS 2 Randomized Clinical Trial.
東亞地區過重或肥胖(合併或未合併第二型糖尿病)族群中口服 Semaglutide 的療效:OASIS 2 隨機臨床試驗
JAMA Intern Med 2025-08-04
Population Health Colorectal Cancer Screening Strategies in Adults Aged 45 to 49 Years: A Randomized Clinical Trial.
45至49歲成人族群健康大腸直腸癌篩檢策略:隨機臨床試驗
JAMA 2025-08-04
Sodium-glucose co-transporter 2 inhibitors reduce the intravitreal anti-VEGF treatment necessity in eyes with early diabetic macular oedema: A post-hoc analysis focusing on the fellow eye of the COMET trial.
Sodium-glucose co-transporter 2 抑制劑可減少早期糖尿病黃斑水腫眼睛對玻璃體內抗VEGF治療的需求:針對 COMET 試驗對側眼的事後分析
Diabetes Obes Metab 2025-08-04
Effects of liraglutide on the testis of rats with experimental diabetes and ischemia-reperfusion injury.
liraglutide 對實驗性糖尿病及缺血再灌流損傷大鼠睪丸的影響
Biotech Histochem 2025-08-04
Effect of Dapagliflozin Treatment on Index of Cardiac Electrophysiological Balance in Patients With Heart Failure With Reduced Ejection Fraction.
Dapagliflozin 治療對射血分率降低型心衰竭患者心臟電生理平衡指數的影響
Ann Noninvasive Electrocardiol 2025-08-04
Association between sodium-glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection.
第二型糖尿病患者在泌尿道感染後使用鈉-葡萄糖共轉運蛋白2抑制劑(SGLT2 inhibitor)與臨床結局之關聯
Diabetes Obes Metab 2025-08-04
Making manual scoring of typed transcripts a thing of the past: a commentary on Herrmann (2025).
讓手動評分打字逐字稿成為過去式:針對 Herrmann (2025) 的評論
Speech Lang Hear 2025-08-04